Notable
OLIGAMI · Metastasis-directed Therapy for Oligometastases of Breast Cancer
Primary completion pushed from Nov 8, 2026 to Nov 8, 2029
Also in this update: Enrollment reduced: 340 → 146 participants; Completion pushed from Oct 31, 2032 to Oct 31, 2035
Tokyo Medical and Dental UniversityPhase 3 NCT06135714 Registry history of NCT06135714 on ClinicalTrials.gov (opens the registry)
Updated